Effect of dibutyryl cyclic AMP on the cyclin-dependent kinase inhibitor p27(Kip1) in the human hepatoma cells PLC/PRF/5

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3287-3291

  Kikukawa, Masaji ^a   Okamoto, Yasuyuki ^a   Fukui, Hiroshi ^a   Nakano, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Antisense oligodeoxynucleotides; Cell cycle; DNA synthesis; Flow cytometry; Immunoblotting

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BUCLADESINE; CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CONTROLLED STUDY; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

BUCLADESINE; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH INHIBITORS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0030730937     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cho-Chung YS, Clair T, Bodwin JS and Berghoffer B: Growth arrest and morphological change of human breast cancer cells by dibutyryl cyclic AMP and L-arginine. Science 214: 77-79, 1981.
2. Giuffre L, Schreyer M, Mach J-P and Carrel S: Cyclic AMP induces differentiation in vitro of human melanoma cells. Cancer 61: 1132-1141, 1988.
3. Van Wijk R, Wicks WD and Clay K: Effects of derivatives of cyclic 3',5'-adenosine monophosphate on the growth, morphology, and gene expression of hepatoma cells in culture. Cancer Res 32: 1905-1911, 1972.
4. Van Wijk R, Wicks WD, Bevers MM and Van Rijin J: Rapid arrest of DNA synthesis by N6,O2'-dibutyryl cyclic adenosine 3',5'-monophosphate in cultured hepatoma cells. Cancer Res 33: 1331-1338, 1973.
5. Nose K and Katsuta H: Arrest of cultured rat liver cells in G2 phase by the treatment with dibutyryl cAMP. Biochem Biophys Res Commun 64: 983-988, 1975.
6. Torii M, Miyake K and Kanai K: Effects of dibutyryl adenosine 3'-5' cyclic monophosphate on the ultrastructure of rat ascites hepatoma cells and on the intracellular localization of α-fetoprotein. Gann 75: 1083-1088, 1984.
7. Tagliaferri P, Katsaros D, Clair T, Ally S, Tortora G, NeckersL, Rubalcava B, Parandoosh Z, Chang Y, Revankar GR, Crabtree GW, Robins RK and Cho-Chung YS: Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues. Cancer Res 48: 1642-1650, 1988.
8. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ and Sturgill TW: Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate. Science 262: 1065-1069, 1993.
9. Cook SJ and McCormick F: Inhibition by cAMP of Ras-dependent activation of Raf. Science 262: 1069-1072, 1993.
10. Sherr CJ: Mammalian G1 cyclins. Cell 73: 1059-1065, 1993.
11. Morgan DO: Principles of CDK regulation. Nature 374: 131-134, 1995.
12. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66, 1994.
13. Kip1) of cyclin-dependent kinase 4 activation. Cell 79: 487-496, 1994.
14. Macnab GM, Alexander JJ, Lecatsas G, Bey EM and Urbanowicz JM: Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer 34: 509-515, 1976.
15. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 762: 156-159, 1987.
16. Coats S, Flanagan WM, Nourse J and Roberts JM: Requirement of p27(Kipl) for restriction point control of the fibroblast cell cycle. Science 272: 877-880, 1996.
17. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF and Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682-685, 1995.
18. Yamashita YM, Nakaseko Y, Samejima I, Kumada K, Yamada H, Michaelson D and Yanagida M: 20S cyclosome complex formation and proteolytic activity inhibited by cAMP/PKA pathway. Nature 384: 276-279, 1996.
19. Steeg PS and Abrams JS: Cancer prognosis: Past, present and p27. Nat Med 3: 152-154, 1997.
20. Glotzer M, Murray AW and Kirschner MW: Cyclin is degraded by the ubiquitin pathway. Nature 349: 132-138, 1991.